Capital Group Private Client Services »

Sarepta Therapeutics shares owned by Capital Group Private Client Services

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Capital Group Private Client Services from 13F filings

Historical chart of Capital Group Private Client Services investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Capital Group Private Client Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Capital Group Private Client Services

Quarter filed Position value Share count Share price at filing
2025-03-31 $8.1M 127k 63.82
2024-12-31 $15M 119k 121.59
2024-09-30 $7.6M 61k 124.89

More positions owned by Capital Group Private Client Services

Capital Group Growth Etf Shs Creation Uni (CGGR)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Capital Group Core Equity Et Shs Creation Uni (CGUS)
Capital Group Dividend Growe Shs Etf (CGDG)
Broadcom (AVGO)
Capital Group Global Equity SHS (CGGE)
Microsoft Corporation (MSFT)
Capital Group Conservative E SHS (CGCV)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Meta Platforms Cl A (META)
Capital Group New Geography SHS (CGNG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Capital Group Private Client Services

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics